tradmap

CI Financials Cigna

10 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 11.4% per year over the past 5 years.
  • Net income has grown slower than revenue (7.4% vs 11.4% per year).
  • Operating margin has contracted, at 3.3% in the latest year.
  • Free cash flow has grown 33.3% per year over the past 5 years.

Shareholder returns

  • Dividends have been paid for 7 consecutive years, consuming 27.0% of earnings.
  • The dividend has grown 154.8% per year over the past 5 years.
Revenue & net income
$0 $137B $275B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
0% 47% 94% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $4B $8B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $21B $41B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$26B -$1B $24B $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $274.9B $6.0B 21.8% 3.3% $7.7B
2024 $247.1B $3.4B 26.1% 3.8% $7.5B
2023 $195.3B $5.2B 31.5% 4.4% $7.8B
2022 $180.5B 30.8% 4.7% $5.9B
2021 $174.1B 32.5% 4.6% $5.1B
2020 $160.4B 35.5% 5.1% $10.2B
2019 $153.6B 36.4% 5.3% $8.4B $4.6B
2018 $48.6B 90.1% 8.6% $3.2B $41.0B $3.9B
2017 $41.8B 94.1% 9.4% $3.6B $3.0B
2016 $39.8B 93.8% 7.8% $3.6B $3.2B

Valuation over time

How the market has priced CI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 13.0 26.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 0.2 0.5 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 1.2 2.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is CI growing its revenue and profit?

Over the past 5 years, Cigna's revenue has grown 11.4% per year, and net income grown 7.4% per year. These are computed facts, not advice.

How much debt does CI have?

As of FY2025, Cigna reported — of total debt against $7.7B of cash.

What is CI's profit margin?

In FY2025, gross margin was 21.8%, operating margin 3.3%, and net margin 2.2%.

What is CI's P/E ratio?

As of Jun '26, Cigna traded at a price-to-earnings ratio of about 12.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.